Competitive binding of viral E2 protein and mammalian core-binding factor to transcriptional control sequences of human papillomavirus type 8 and bovine papillomavirus type 1

Journal of Virology

Volumn 71, Issue 10, 1997, Pages 8029-8034

  Schmidt, Hanns Martin ^a   Steger, Gertrud ^a   Pfister, Herbert ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR; VIRUS PROTEIN;

ARTICLE; BINDING COMPETITION; BINDING SITE; CONTROLLED STUDY; DNA BINDING; GENE REPRESSION; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION; WART VIRUS;

EID: 0030865217     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.10.8029-8034.1997     Document Type: Article

References (40)

1. Asselineau, D., B. A. Bernard, C. Bailly, M. Darmon, and M. Pruniéras. 1986. Human epidermis reconstructed by culture: is it "normal"? J. Investig. Dermatol. 86:181-186.
2. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1992. Short protocols in molecular biology. Greene Publishing and Wiley Interscience, New York, N.Y.
3. Bae, S. C., E. Ogawa, M. Maruyama, H. Oka, M. Satake, K. Shigesada, N. A. Jenkins, D. J. Gilbert, N. G. Copeland, and Y. Ito. 1994. PEBP2αB/mouse AML1 consists of multiple isoforms that possess different transactivation potentials. Mol. Cell. Biol. 14:3242-3252.
4. Banerjee, C., S. W. Hiebert, J. L. Stein, J. B. Lian, and G. S. Stein. 1996. An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionaily activates the ostcocalcin gene. Proc. Natl. Acad. Sci. USA 93:4968-4973.
5. Dong, X.-P., F. Stubenrauch, E. Beyer-Finkler, and H. Pfister. 1994. Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers. Int. J. Cancer 58:803-808.
6. Fuchs, P. G., and H. Pfister. 1997. Molecular biology of HPV and mechanisms of keratinocyte transformation, p. 15-46. In G. Gross and G. von Krogh (ed.), Human papillomavirus infections in dermatovenercology. CRC Press, Boca Raton, Fla.
7. Furukawa, K., Y. Yamaguchi, E. Ogawa, K. Shigesada, M. Satake, and Y. Ito. 1990. A ubiquitous repressor interacting with an F9 cell-specific silencer and its functional suppression by differentiated cell-specific positive factors. Cell Growth Differ. 1:135-147.
8. Giese, K., C. Kingsley, J. R. Kirshner, and R. Grosschedl. 1995. Assembly and function of a TCRα enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev. 9:995-1008.
9. Hiebert, S. W., W. Sun, J. N. Davis, T. Golub, S. Shurtleff, A. Buijs, J. R. Downing, G. Grosveld, M. F. Roussel, D. G. Gilliland, N. Lenny, and S. Meyers. 1996. The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Mol. Cell. Biol. 16:1349-1355.
10. Horn, S., H. Pfister, and P. G. Fuchs. 1993, Constitutive transcriptional activator of epidermodysplasia verruciformis-associated human papillomavirus 8. Virology 196:674-681.
11. Jackson, M. E., and M. S. Campo. 1995. Both viral E2 protein and the cellular factor PEBP2 regulate transcription via E2 consensus sites within the bovine papillomavirus type 4 long control region. J. Virol. 69:6038-6046.
12. Kamachi, Y., E. Ogawa, M. Asano, S. Ishida, Y. Murakami, M. Satake, Y. Ito, and K. Shigesada, 1990. Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer. J. Virol. 64:4808-4819.
13. Levine, M., and J. C. Manley. 1989. Transcriptional repression of eukaryotic promoters. Cell 59:405-408.
14. Melnikova, I. N., B. E. Crute, S. Wang, and N. A. Speck. 1993. Sequence specificity of the core-binding factor. J. Virol. 67:2408-2411.
15. Meyers, C., M. G. Fratdni, J. B. Hudson, and L. A. Laimins. 1992. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 257:971-973.
16. Meyers, S., J. R. Downing, and S.W. Hiebert. 1993. Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions. Mol. Cell. Biol. 13:6336-6345.
17. Meyers, S., N. Lenny, and S. W. Hiebert. 1995. The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation. Mol. Cell. Biol. 15:1974-1982.
18. Ogawa, E., M. Maruyama, H. Kagoshima, M. Inuzuka, J. Lu, M. Satake, K. Shigesada, and Y. Ito. 1993. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc. Natl. Acad, Sci. USA 90:6859-6863.
19. Ogawa, E., M. Inuzuka, M. Maruyama, M. Satake, M. Naito-Fujimoto, Y. Ito, and K. Shigesada. 1993. Molecular cloning and characterization of PEBP2β, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2α. Virology 194:314-331.
20. Purdie, K. J., C. J. Sexton, C. M. Proby, M. T. Glover, A. T. Williams, J. N. Stables, and I. M. Leigh. 1993. Malignant transformation of cutaneous lesions in renal allograft patients: a role for human papillomavirus? Cancer Res. 53:5328-5333.
21. Reh, H., and H. Pfister. 1990. Human papillomavirus type 8 contains cis-active positive and negative transcriptional control sequences. J. Gen. Virol. 71:2457-2462.
22. Rutberg, S. E., L. R. Dolan, and Z. Ronai. 1994. PEBP2 - a modulator of polyoma DNA replication. DNA Cell Biol. 13:865-874.
23. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with "mini extracts'" prepared from a small number of cells. Nucleic Acids Res. 17:6419.
24. 23a.Steger, G. Unpublished data.
25. Steger, G., J. Ham, F. Thierry, and M. Yaniv. 1993. The E2 proteins of papillomaviruses as transcription and replication factors, p. 263-278. In W. Doerfler and P. Boehm (ed.), Virus strategies. VCH, Weinheim, Germany.
26. Steger, G., J. Ham, O. Lefebvre, and M. Yaniv. 1995. The bovine papillomavirus 1 E2 protein contains two activation domains: one that interacts with TBP and another that functions after TBP binding, EMBO J. 14:329-340.
27. Steger, G., and S. Corbach. 1997. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. J. Virol. 71:50-58.
28. Stenlund, A., and M. R. Botchan. 1990. The E2 trans-activator can act as a repressor by interfering with a cellular transcription factor. Genes Dev. 4:123-136.
29. Stubenrauch, F., J. Malejczyk, P. Fuchs, and H. Pfister, 1992. Late promoter of human papillomavirus type 8 and its regulation. J. Virol. 66:3485-3493.
30. Stubenrauch, F., and H. Pfister. 1994. Low-affinity E2-binding site mediates downmodulation of E2 transactivation of the human papillomavirus type 8 late promoter. J. Virol. 68:6959-6966.
31. Stubenrauch, F., I. M. Leigh, and H. Pfister. 1996. E2 represses the late gene promoter of human papillomavirus type 8 at high concentrations by interfering with cellular factors. J. Virol. 70:119-126.
32. Takahashi, A., M. Satake, Y. Yamaguchi-Iwai, S.-C. Bae, J. Lu, M. Maruyama, Y. W. Zhang, H. Oka, N. Arai, K. Arai, and Y. Ito. 1995. Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AML1-related transcription factor, PEBP2. Blood 86:607-616.
33. Vande Pol, S. B., and P. M. Howley. 1990. A bovine papillomavirus constitutive enhancer is negatively regulated by the E2 repressor through competitive binding for a cellular factor. J. Virol. 64:5420-5429.
34. Wang, Q., T. Stacy, J. D. Miller, A. F. Lewis, T.-L. Gu, X. Huang, J. H. Bushweller, J.-C. Bories, F. W. Alt, G. Ryan, P. P. Liu, A. Wynshaw-Boris, M. Binder, M. Marin-Padilla, A. H. Sharpe, and N. A. Speck. 1996. The CBFβ subunit is essential for CBF7alpha;2 (AML1) function in vivo. Cell 87:697-708.
35. Wang, S., Q. Wang, B. E. Crute, I. N. Melnikova, S. R. Keller, and N. A. Speck. 1993. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol. Cell. Biol. 13:3324-3339.
36. Wasylyk, B., J. L. Imler, B. Chatton, C. Schatz, and C. Wasylyk. 1988. Negative and positive factors determine the activity of the polyoma virus enhancer a domain in undifferentiated and differentiated cell types. Proc. Natl. Acad. Sci. USA 85:7952-7956.
37. Wotton, D., J. Ghysdael, S. Wang, N. A. Speck, and M. J. Owen. 1994. Cooperative binding of Ets-1 and core binding factor to DNA. Mol. Cell. Biol. 14:840-850.
38. Yang, Y.-C., H. Okayama, and P. M. Howley. 1985. Bovine papillomavirus contains multiple transforming genes. Proc. Natl. Acad. Sci. USA 82:1030-1034.
39. Zaiman, A. L., A. F. Lewis, B. E. Crute, N. A. Speck, and J. Lenz. 1995. Transcriptional activity of core binding factor α (AML1) and β subunits on murine leukemia virus enhancer cores. J. Virol. 69:2898-2906.
40. Zaiman, A. L., and J. Lenz. 1996. Transcriptional activation of a retrovirus enhancer by CBF (AML1) requires a second factor: evidence for cooperativity with c-myb. J. Virol. 70:5618-5629.